IP Library Patent Application 12404240
Patent Application
App. No. 12/404,240

COMPOSITIONS AND METHODS FOR ANALYSIS OF NUCLEIC ACID MOLECULES DURING AMPLIFICATION REACTIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/404,240
Filed
Mar 13, 2009
Art Unit
1637
USPC
435/6
Abstract

The present invention provides systems, methods and kits for performing a detection assay (e.g., invasive cleavage assay) in combination with an amplification assay (e.g., PCR), where the detection assay employs enzyme footprint probes with relatively short (e.g., 6-12 bases) analyte-specific regions configured to provide a preferred footprint length of duplex for use with a particular nucleic acid modifying enzyme. In some embodiments, such assays are used for target quantification, and in other embodiments, such assays are used for genotyping. In certain embodiments, the use of such short probes allows for assays with increased dynamic range.

Claims (31)

1 . A composition for analysis of a target nucleic acid, comprising: a) amplification primers; b) a polymerase; c) a FEN-1 endonuclease; and d) a synthetic probe comprising an analyte-specific portion and a non-target portion, wherein said non-target portion is substantially non-complementary to said target nucleic acid and wherein said analyte-specific portion is no more than 12 nucleotides in length, and contains up to 12 nucleotides that are complementary to said target nucleic acid.

2 . The composition of claim 1 , wherein said analyte specific portion of said synthetic probe has a calculated T m with respect to said target nucleic acid at least 5° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

3 . The composition of claim 2 , wherein said analyte specific portion of said synthetic probe has a calculated T m with respect to said target nucleic acid at least 8° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

4 . The composition of claim 3 , wherein said analyte specific portion of said synthetic probe has a calculated T m with respect to said target nucleic acid at least 10° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

5 . The composition of claim 1 , further comprising a reverse transcriptase enzyme.

6 . The composition of claim 1 , wherein said polymerase is a thermostable DNA polymerase.

7 . The composition of claim 6 , wherein said thermostable DNA polymerase lack 5′ to 3′ exonuclease activity.

8 . The composition of claim 1 , wherein said FEN-1 endonuclease is a thermostable FEN-1 endonuclease.

9 . The composition of claim 1 , wherein said FEN-1 endonuclease is from an archaeal species.

10 . The composition of claim 1 , further comprising a second oligonucleotide configured to form a cleavage structure with said probe in the presence of said target nucleic acid, wherein said cleavage structure is formed by association of said target nucleic acid with: a) said probe hybridized at a first region of said target nucleic acid; and b) said second oligonucleotide hybridized at a second region of said target nucleic, wherein said second region is downstream of said first region.

11 . The composition of claim 10 , wherein said second region of said target nucleic acid is contiguous with and downstream of said first region of said target nucleic acid.

12 . The composition of claim 11 , wherein at least one nucleotide at the 3′ end of the second oligonucleotide, when associated with said target in a cleavage structure, overlaps with a region of hybridization between said probe and said target nucleic acid.

13 . The composition of claim 12 , wherein the 3′ terminal nucleotide of said second oligonucleotide is not complementary to said target nucleic acid, when said second oligonucleotide is associated with said target nucleic acid in said cleavage structure.

14 . The composition of claim 1 , wherein said synthetic probe is unlabeled.

15 . The composition of claim 1 , wherein said synthetic probe does not contain non-natural nucleotides.

16 . The composition of claim 1 , wherein said synthetic probe does not comprise a minor groove binder moiety.

17 . The composition of claim 1 , further comprising a synthetic detection oligonucleotide having a region complementary to said non-target portion of said synthetic probe.

18 . The composition of claim 17 , wherein said synthetic detection oligonucleotide has a region of self-complementarity that forms a hairpin structure.

19 . The composition of claim 17 , wherein said synthetic detection oligonucleotide comprises a label.

20 . The composition of claim 19 , wherein said label is a fluorescent label.

21 . The composition of claim 20 , wherein said synthetic detection oligonucleotide further comprises a fluorescence quencher moiety.

22 . The composition of claim 1 , further comprising a target nucleic acid.

23 . A composition comprising: a) a target nucleic acid; b) amplification primers; c) a polymerase; d) a FEN-1 endonuclease; and e) a synthetic probe comprising an analyte-specific portion and a non-target portion, wherein said non-target portion is substantially non-complementary to said target nucleic acid, and wherein said analyte-specific portion of said synthetic probe has a calculated T m with respect to said target nucleic acid that is at least 5° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

24 . The composition of claim 23 , wherein said wherein said analyte-specific portion of said unlabeled synthetic probe has a calculated T m with respect to said target nucleic acid that is at least 8° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

25 . The composition of claim 23 , wherein said wherein said analyte-specific portion of said unlabeled synthetic probe has a calculated T m with respect to said target nucleic acid that is at least 10° C. below the calculated T m of at least one of said amplification primers with respect to said target nucleic acid.

26 . The composition of claim 23 , further comprising a synthetic detection oligonucleotide having a region complementary to said non-target portion of said synthetic probe.

27 . The composition of claim 26 , wherein said synthetic detection oligonucleotide has a region of self-complementarity that forms a hairpin structure.

28 . The composition of claim 26 , wherein said synthetic detection oligonucleotide comprises a label.

29 . The composition of claim 28 , wherein said label is a fluorescent label.

30 . The composition of claim 29 , wherein said synthetic detection oligonucleotide further comprises a fluorescence quencher moiety.

31 . The composition of claim 23 , further comprising a second oligonucleotide configured to form a cleavage structure with said probe in the presence of said target nucleic acid, wherein said cleavage structure is formed by association of said target nucleic acid with: a) said synthetic probe hybridized at a first region of said target nucleic acid; and b) said second oligonucleotide hybridized at a second region of said target nucleic, wherein said second region is downstream of said first region.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 022680 FRAME 0672. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE NAME SHOULD BE 'HOLOGIC, INC.', NOT 'THIRD WAVE TECHNOLOGIES, INC.'. Recorded Sep 2, 2010
From: ALLAWI, HATIM T.
To: HOLOGIC, INC.
Reel/Frame 024936/0213 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2009
From: ALLAWI, HATIM T.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 022680/0672 →
SIXTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Apr 21, 2009
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 022572/0102 →